5/10
11:25 am
rna
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $33.00 price target on the stock.
Low
Report
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $33.00 price target on the stock.
5/10
10:09 am
rna
Rating for RNA
Low
Report
Rating for RNA
5/10
08:39 am
rna
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $35.00 price target on the stock.
Medium
Report
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $35.00 price target on the stock.
5/10
06:59 am
rna
Rating for RNA
Medium
Report
Rating for RNA
5/10
06:59 am
rna
Rating for RNA
Medium
Report
Rating for RNA
4/11
08:06 am
rna
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $35.00 price target on the stock.
Low
Report
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $35.00 price target on the stock.
4/11
07:21 am
rna
Rating for RNA
Low
Report
Rating for RNA
4/11
07:21 am
rna
Rating for RNA
Low
Report
Rating for RNA
3/14
08:30 am
rna
Avidity Biosciences, Inc. (NASDAQ: RNA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $60.00 price target on the stock.
Medium
Report
Avidity Biosciences, Inc. (NASDAQ: RNA) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $60.00 price target on the stock.
3/14
07:35 am
rna
Rating for RNA
Medium
Report
Rating for RNA
3/14
06:28 am
rna
Avidity Biosciences initiated with bullish view at Cantor Fitzgerald
Medium
Report
Avidity Biosciences initiated with bullish view at Cantor Fitzgerald
3/5
05:07 am
rna
Rating for RNA
Medium
Report
Rating for RNA
3/4
01:09 pm
rna
Rating for RNA
Low
Report
Rating for RNA
3/4
01:09 pm
rna
Rating for RNA
Low
Report
Rating for RNA
2/29
09:10 am
rna
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $35.00 price target on the stock.
Low
Report
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $35.00 price target on the stock.
2/29
08:49 am
rna
Rating for RNA
Low
Report
Rating for RNA
2/29
08:49 am
rna
Rating for RNA
Low
Report
Rating for RNA
2/29
08:16 am
rna
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $23.00 price target on the stock.
Low
Report
Avidity Biosciences, Inc. (NASDAQ: RNA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $23.00 price target on the stock.
2/29
08:07 am
rna
Rating for RNA
Low
Report
Rating for RNA